Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover

Richard Eastell; Rosemary A. Hannon; Dietrich Wenderoth; Jesus Rodriguez-Moreno; Andrzej Sawicki

首页> 外文期刊>The journal of clinical endocrinology and metabolism >Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover

【24h】

Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover

机译：长期治疗后停用雷升膦酸盐对骨周转率的影响

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Context:Determining how quickly bisphosphonate treatment effects begin to regress is crucial when considering termination of treatment.

机译：背景：在考虑终止治疗时，确定双膦酸盐治疗效果开始下降的速度至关重要。

著录项

来源
《The journal of clinical endocrinology and metabolism》 |2011年第11期|共7页
作者
Richard Eastell; Rosemary A. Hannon; Dietrich Wenderoth; Jesus Rodriguez-Moreno; Andrzej Sawicki;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. RELATIONSHIP BETWEEN SUPPRESSION OF BONE TURNOVER MARKERS AND FUTURE INCREASES IN BONE MINERAL DENSITY IN RISEDRONATE TREATMENT [J] . Mawatari T. M., Muraoka M., Iwamoto Y. I. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2016,第Suppla1期

机译：利多酸治疗中骨转换标志的抑制与骨密度的未来增加之间的关系
2. Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate [J] . BrownJ.P., RouxC., HoP.R., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2014,第7期

机译：与绝经后妇女相比，尽管先前曾接受口服双膦酸盐的次优治疗，但骨折风险仍然较高的绝经后妇女与每月口服伊班膦酸钠和利塞膦酸盐相比，地诺单抗显着增加了骨矿物质密度并减少了骨转换
3. Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate [J] . BrownJ.P., RouxC., HoP.R., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2014,第7期

机译：Deaosumab显着提高骨矿物质密度，并与每月口腔母母母母植物和日期前孕妇中的骨头植物和日式疗法减少骨质营业额，尽管以口服双膦酸盐次次替次替代治疗较高的裂缝风险
4. The long-term follow-up of calcium hydroxyapatite ceramic implantation for the treatment of bone tumors [C] . A. Uchida, Y. Yamashita, J. Sonoda, International symposium on ceramics in medicine . 1999

机译：羟基磷灰石钙陶瓷植入治疗骨肿瘤的长期随访
5. The effects of phytochemicals on bone turnover and validation of a novel method to assess bone turnover. [D] . Cheong, Jennifer Mei Kuin. 2005

机译：植物化学物质对骨转换的影响和评估骨转换的新方法的验证。
6. Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover [O] . Richard Eastell, Rosemary A. Hannon, Dietrich Wenderoth, -1

机译：长期治疗后停用雷升膦酸盐对骨周转的影响
7. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate [O] . Hosking, David, Lyles, Kenneth, Brown, Jacques P, 2007

机译：唑来膦酸和利塞膦酸盐可长期控制Paget病的骨转换

Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover

摘要

著录项

相似文献

相关主题

期刊订阅